loadpatents
Patent applications and USPTO patent grants for Patil; Namrata.The latest application filed is for "afucosylated anti-fgfr2iiib antibodies".
Patent | Date |
---|---|
Afucosylated Anti-FGFR2IIIB Antibodies App 20220168416 - Harding; Thomas ;   et al. | 2022-06-02 |
Afucosylated anti-FGFR2IIIB antibodies Grant 11,235,059 - Harding , et al. February 1, 2 | 2022-02-01 |
Method Of Monitoring Effectiveness Of Immunotherapy Of Cancer Patients App 20210292851 - Balasubramanyam; Aarthi ;   et al. | 2021-09-23 |
Afucosylated Anti-FGFR2IIIB Antibodies App 20190175730 - Harding; Thomas ;   et al. | 2019-06-13 |
Method of treatment of malignant solid tumors with afucosylated anti-FGFR2IIIb antibodies Grant 10,172,937 - Harding , et al. J | 2019-01-08 |
Afucosylated Anti-fgfr2iiib Antibodies App 20160339100 - Harding; Thomas ;   et al. | 2016-11-24 |
Afucosylated Anti-fgfr2iiib Antibodies App 20150050273 - Harding; Thomas ;   et al. | 2015-02-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.